Biogen Cash on Hand 2006-2020 | BIIB

Biogen cash on hand from 2006 to 2020. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
  • Biogen cash on hand for the quarter ending March 31, 2020 was $3.860B, a 1.24% decline year-over-year.
  • Biogen cash on hand for 2019 was $4.476B, a 26.51% increase from 2018.
  • Biogen cash on hand for 2018 was $3.538B, a 4.09% decline from 2017.
  • Biogen cash on hand for 2017 was $3.689B, a 24.64% decline from 2016.
Biogen Annual Cash on Hand
(Millions of US $)
2019 $4,476
2018 $3,538
2017 $3,689
2016 $4,895
2015 $3,429
2014 $1,845
2013 $1,223
2012 $1,706
2011 $1,691
2010 $1,208
2009 $1,264
2008 $1,401
2007 $1,392
2006 $903
2005 $851
Biogen Quarterly Cash on Hand
(Millions of US $)
2020-03-31 $3,860
2019-12-31 $4,476
2019-09-30 $4,437
2019-06-30 $2,952
2019-03-31 $3,909
2018-12-31 $3,538
2018-09-30 $4,428
2018-06-30 $3,224
2018-03-31 $5,916
2017-12-31 $3,689
2017-09-30 $3,508
2017-06-30 $2,893
2017-03-31 $2,880
2016-12-31 $4,895
2016-09-30 $4,316
2016-06-30 $3,797
2016-03-31 $3,585
2015-12-31 $3,429
2015-09-30 $5,843
2015-06-30 $2,369
2015-03-31 $2,152
2014-12-31 $1,845
2014-09-30 $1,861
2014-06-30 $1,573
2014-03-31 $1,260
2013-12-31 $1,223
2013-09-30 $669
2013-06-30 $668
2013-03-31 $663
2012-12-31 $1,706
2012-09-30 $1,606
2012-06-30 $1,406
2012-03-31 $1,277
2011-12-31 $1,691
2011-09-30 $1,520
2011-06-30 $1,327
2011-03-31 $1,229
2010-12-31 $1,208
2010-09-30 $825
2010-06-30 $970
2010-03-31 $1,153
2009-12-31 $1,264
2009-09-30 $1,408
2009-06-30 $1,623
2009-03-31 $1,401
2008-12-31 $1,401
2008-09-30 $1,565
2008-06-30 $1,039
2008-03-31 $1,111
2007-12-31 $1,392
2007-09-30 $671
2007-06-30 $1,803
2007-03-31 $1,128
2006-12-31 $903
2006-09-30 $661
2006-06-30 $714
2006-03-31 $849
2005-12-31 $851
2005-09-30 $611
2005-06-30 $927
2005-03-31 $1,152
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $45.724B $14.378B
Biogen is a leading biopharmaceutical company engaged in the research, development and marketing of targeted therapies for the treatment of cancer, autoimmune and inflammatory diseases. The company owns industry leading brands for the treatment of multiple sclerosis, next-generation treatments for hemophilia, and a deep clinical pipeline ranging from Alzheimer's disease, lupus nephritis to neuropathic pain.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $147.997B 16.30
Bristol Myers Squibb (BMY) United States $134.766B 11.26
Gilead Sciences (GILD) United States $94.843B 12.29
CSL (CSLLY) Australia $89.938B 0.00
Vertex Pharmaceuticals (VRTX) United States $76.725B 52.75
Regeneron Pharmaceuticals (REGN) United States $70.449B 27.16
Illumina (ILMN) United States $54.371B 55.87
Seattle Genetics (SGEN) United States $30.385B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $24.107B 0.00
Alexion Pharmaceuticals (ALXN) United States $23.849B 10.25
Incyte (INCY) United States $23.535B 0.00
BioMarin Pharmaceutical (BMRN) United States $23.279B 211.03
Genmab (GMAB) Denmark $23.005B 18.95
Moderna (MRNA) United States $22.860B 0.00
Genmab (GNMSF) Denmark $21.647B 64.27
Alnylam Pharmaceuticals (ALNY) United States $18.506B 0.00
BeiGene (BGNE) Cayman Islands $15.873B 0.00
BioNTech SE (BNTX) Germany $15.286B 0.00
Exact Sciences (EXAS) United States $13.742B 0.00
Sarepta Therapeutics (SRPT) United States $13.270B 0.00
Galapagos (GLPG) Belgium $13.081B 38.48
Bio-Rad Laboratories (BIO.B) United States $12.955B 58.97
ARGENX SE-ADR (ARGX) Netherlands $11.817B 0.00
Horizon Therapeutics Public (HZNP) Ireland $11.210B 27.59
Bio-Techne Corp (TECH) United States $10.473B 69.19
QIAGEN (QGEN) Netherlands $9.923B 28.85
Immunomedics (IMMU) United States $9.594B 0.00
ACADIA Pharmaceuticals (ACAD) United States $8.791B 0.00
Guardant Health (GH) United States $8.241B 0.00
Exelixis (EXEL) United States $7.334B 25.72
Ascendis Pharma (ASND) Denmark $6.971B 0.00
Repligen (RGEN) United States $6.553B 114.94
Adaptive Biotechnologies (ADPT) United States $6.193B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $5.835B 125.56
Novavax (NVAX) United States $5.697B 0.00
Acceleron Pharma (XLRN) United States $5.505B 0.00
Vir Biotechnology (VIR) United States $5.432B 0.00
Ultragenyx Pharmaceutical (RARE) United States $5.369B 0.00
Reata Pharmaceuticals (RETA) United States $5.251B 0.00
Mirati Therapeutics (MRTX) United States $5.193B 0.00
Zai Lab (ZLAB) China $5.048B 0.00
Emergent Biosolutions (EBS) United States $4.950B 32.44
MyoKardia (MYOK) United States $4.448B 0.00
MorphoSys AG (MOR) Germany $4.393B 34.07
Blueprint Medicines (BPMC) United States $4.263B 0.00
China Biologic Products (CBPO) China $4.244B 23.59
Global Blood Therapeutics (GBT) United States $4.165B 0.00
Amicus Therapeutics (FOLD) United States $4.066B 0.00
Momenta Pharmaceuticals (MNTA) United States $4.061B 0.00
Halozyme Therapeutics (HALO) United States $3.872B 0.00
NeoGenomics (NEO) United States $3.804B 277.77
Inovio Pharmaceuticals (INO) United States $3.709B 0.00
Bluebird Bio (BLUE) United States $3.692B 0.00
Arena Pharmaceuticals (ARNA) United States $3.346B 0.00
Alkermes (ALKS) Ireland $3.239B 63.77
Deciphera Pharmaceuticals (DCPH) United States $3.173B 0.00
Fate Therapeutics (FATE) United States $2.930B 0.00
Insmed (INSM) United States $2.869B 0.00
Denali Therapeutics (DNLI) United States $2.863B 0.00
Amarin (AMRN) Ireland $2.610B 0.00
PHARMA MAR SA (PHMMF) Spain $2.470B 0.00
Twist Bioscience (TWST) United States $2.237B 0.00
Viela Bio (VIE) United States $2.207B 0.00
UniQure (QURE) Netherlands $2.075B 0.00
Alector (ALEC) United States $1.920B 0.00
Editas Medicine (EDIT) United States $1.913B 0.00
Eidos Therapeutics (EIDX) United States $1.898B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.896B 0.00
Principia Biopharma (PRNB) United States $1.863B 0.00
Ligand Pharmaceuticals (LGND) United States $1.797B 69.98
Forma Therapeutics Holdings (FMTX) United States $1.741B 0.00
Adverum Biotechnologies (ADVM) United States $1.738B 0.00
Zymeworks (ZYME) Canada $1.698B 0.00
I-Mab (IMAB) China $1.673B 0.00
Intra-Cellular Therapies (ITCI) United States $1.665B 0.00
Epizyme (EPZM) United States $1.642B 0.00
Cytokineticsorporated (CYTK) United States $1.601B 0.00
Mersana Therapeutics (MRSN) United States $1.530B 0.00
Sorrento Therapeutics (SRNE) United States $1.529B 0.00
Mesoblast (MESO) Australia $1.509B 0.00
Sangamo Therapeutics (SGMO) United States $1.495B 0.00
Beam Therapeutics (BEAM) United States $1.494B 0.00
Revance Therapeutics (RVNC) United States $1.488B 0.00
NantKwest (NK) United States $1.477B 0.00
Zealand Pharma (ZEAL) Denmark $1.469B 0.00
Intercept Pharmaceuticals (ICPT) United States $1.451B 0.00
REGENXBIO (RGNX) United States $1.449B 0.00
Akcea Therapeutics (AKCA) United States $1.404B 0.00
Zealand Pharma (ZLDPF) Denmark $1.369B 0.00
NGM Biopharmaceuticals (NGM) United States $1.353B 0.00
Arvinas (ARVN) United States $1.328B 0.00
Intellia Therapeutics (NTLA) United States $1.281B 0.00
Coherus BioSciences (CHRS) United States $1.276B 8.91
Adaptimmune Therapeutics (ADAP) United Kingdom $1.223B 0.00
Arcus Biosciences (RCUS) United States $1.164B 0.00
Athenex (ATNX) United States $1.091B 0.00
Compugen (CGEN) Israel $1.090B 0.00
Alcobra (ARCT) United States $1.018B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.986B 0.00
VBI Vaccines (VBIV) United States $0.911B 0.00
Retrophin (RTRX) United States $0.899B 0.00
Dynavax Technologies (DVAX) United States $0.868B 0.00
Myriad Genetics (MYGN) United States $0.868B 44.77
Heska (HSKA) United States $0.847B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.834B 35.83
Cara Therapeutics (CARA) United States $0.830B 0.00
Pharming Group (PHGUF) Netherlands $0.820B 21.83
Intrexon (PGEN) United States $0.775B 0.00
Morphic Holding (MORF) United States $0.766B 0.00
Kadmon Holdings (KDMN) United States $0.752B 0.00
Cellectis S.A (CLLS) France $0.750B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.735B 0.00
Castle Biosciences (CSTL) United States $0.723B 0.00
Frequency Therapeutics (FREQ) United States $0.712B 0.00
Codexis (CDXS) United States $0.708B 0.00
Vericel (VCEL) United States $0.686B 126.75
ZIOPHARM Oncology Inc (ZIOP) United States $0.685B 0.00
Cue Biopharma (CUE) United States $0.670B 0.00
Agenus (AGEN) United States $0.658B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.642B 0.00
Sinovac Biotech (SVA) China $0.640B 20.87
Vanda Pharmaceuticals (VNDA) United States $0.632B 5.41
AnaptysBio (ANAB) United States $0.621B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.599B 0.00
MiMedx (MDXG) United States $0.591B 0.00
Kala Pharmaceuticals (KALA) United States $0.581B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.566B 0.00
Athersys (ATHX) United States $0.550B 0.00
Syros Pharmaceuticals (SYRS) United States $0.548B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.535B 0.00
Cel-Sci (CVM) United States $0.527B 0.00
Clovis Oncology (CLVS) United States $0.519B 0.00
UROGEN PHARMA (URGN) United States $0.513B 0.00
NextCure (NXTC) United States $0.512B 0.00
Protagonist Therapeutics (PTGX) United States $0.511B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.506B 0.00
Scholar Rock Holding (SRRK) United States $0.502B 0.00
Anika Therapeutics (ANIK) United States $0.501B 16.12
DBV Technologies S.A (DBVT) France $0.494B 0.00
AC Immune SA (ACIU) Switzerland $0.491B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.467B 0.00
MeiraGTx Holdings (MGTX) United States $0.466B 0.00
Geron (GERN) United States $0.443B 0.00
Merus (MRUS) Netherlands $0.443B 0.00
Prothena (PRTA) Ireland $0.436B 0.00
Precision BioSciences (DTIL) United States $0.430B 0.00
Seres Therapeutics (MCRB) United States $0.428B 0.00
BioDelivery Sciences (BDSI) United States $0.428B 22.47
Aeglea BioTherapeutics (AGLE) United States $0.410B 0.00
Puma Biotechnology (PBYI) United States $0.403B 0.00
MannKind (MNKD) United States $0.388B 0.00
CytomX Therapeutics (CTMX) United States $0.385B 0.00
Albireo Pharma (ALBO) United States $0.382B 0.00
Kamada (KMDA) Israel $0.371B 15.44
Avid Bioservices (CDMO) United States $0.369B 0.00
WAVE Life Sciences (WVE) Singapore $0.357B 0.00
ANI Pharmaceuticals (ANIP) United States $0.352B 6.97
Affimed (AFMD) Germany $0.349B 0.00
OSMOTICA PHARM (OSMT) United States $0.328B 0.00
Prometic Life Sciences (LMNL) Canada $0.328B 0.00
PDL BioPharma (PDLI) United States $0.324B 284.00
Starpharma Holdings (SPHRY) Australia $0.313B 0.00
Cellular Biomedicine (CBMG) United States $0.303B 0.00
ChromaDex (CDXC) United States $0.293B 0.00
Spero Therapeutics (SPRO) United States $0.291B 0.00
Abeona Therapeutics (ABEO) United States $0.286B 0.00
Menlo Therapeutics (MNLO) United States $0.285B 0.00
Pfenex (PFNX) United States $0.282B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.275B 0.00
Celldex Therapeutics (CLDX) United States $0.274B 0.00
IBio (IBIO) United States $0.273B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.261B 0.00
Northwest Biotherapeutics (NWBO) United States $0.256B 0.00
IVERIC Bio (ISEE) United States $0.253B 0.00
ADMA Biologics Inc (ADMA) United States $0.250B 0.00
Verastem (VSTM) United States $0.249B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.247B 0.00
Dyadic (DYAI) United States $0.246B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.238B 0.00
Selecta Biosciences (SELB) United States $0.238B 0.00
Five Prime Therapeutics (FPRX) United States $0.236B 0.00
Gritstone Oncology (GRTS) United States $0.234B 0.00
Fortress Biotech (FBIO) United States $0.234B 0.00
HOOKIPA Pharma (HOOK) United States $0.225B 0.00
Pluristem Therapeutics (PSTI) Israel $0.222B 0.00
Aduro Biotech (ADRO) United States $0.218B 0.00
Aptinyx (APTX) United States $0.218B 0.00
XOMA (XOMA) United States $0.214B 0.00
Liquidia Technologies (LQDA) United States $0.214B 0.00
GENFIT S.A (GNFT) France $0.210B 0.00
Strongbridge Biopharma (SBBP) United States $0.208B 0.00
Exicure (XCUR) United States $0.207B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.206B 3.11
Sutro Biopharma (STRO) United States $0.197B 0.00
POXEL SA FRANCE (PXXLF) France $0.190B 0.00
ARAVIVE, INC (ARAV) United States $0.185B 0.00
Bellus Health (BLU) Canada $0.179B 0.00
Trevena (TRVN) United States $0.173B 0.00
Theratechnologies (THTX) Canada $0.170B 0.00
Kindred Biosciences (KIN) United States $0.161B 0.00
CorMedix Inc (CRMD) United States $0.161B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.160B 0.00
Aytu Bioscience (AYTU) United States $0.159B 0.00
Cyclerion Therapeutics (CYCN) United States $0.158B 0.00
VTv Therapeutics (VTVT) United States $0.156B 0.00
Cerecor (CERC) United States $0.155B 0.00
Applied Genetic Technologies (AGTC) United States $0.154B 0.00
Cidara Therapeutics (CDTX) United States $0.153B 0.00
TELA Bio (TELA) United States $0.151B 0.00
Enzo Biochem (ENZ) United States $0.145B 0.00
Celyad SA (CYAD) Belgium $0.143B 0.00
Lumos Pharma (LUMO) United States $0.136B 0.00
VolitionRX (VNRX) United States $0.136B 0.00
Biofrontera AG (BFRA) Germany $0.135B 0.00
PHASEBIO PHARMA (PHAS) United States $0.134B 0.00
Orgenesis (ORGS) United States $0.131B 0.00
Oncobiologics (OTLK) United States $0.131B 0.00
Arbutus Biopharma (ABUS) United States $0.130B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.120B 0.00
Palatin Technologies (PTN) United States $0.119B 3.06
Lineage Cell Therapeutics (LCTX) United States $0.118B 0.00
Celsion (CLSN) United States $0.117B 0.00
Protalix BioTherapeutics (PLX) Israel $0.115B 0.00
AIT Therapeutics (XAIR) United States $0.115B 0.00
AquaBounty Technologies (AQB) United States $0.109B 0.00
Eton Pharmaceuticals (ETON) United States $0.109B 0.00
Checkpoint Therapeutics (CKPT) United States $0.106B 0.00
DiaMedica Therapeutics (DMAC) United States $0.098B 0.00
Cardiff Oncology (CRDF) United States $0.095B 0.00
Windtree Therapeutics (WINT) United States $0.095B 0.00
Cocrystal Pharma (COCP) United States $0.094B 0.00
Unum Therapeutics (UMRX) United States $0.092B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.090B 0.00
Antibe Therapeutics (ATBPF) Canada $0.088B 0.00
Emmaus Life Sciences (EMMA) United States $0.086B 0.00
Organovo Holdings (ONVO) United States $0.084B 0.00
Clearside Biomedical (CLSD) United States $0.084B 0.00
Adocia (ADOCY) France $0.080B 0.00
SESEN BIO, INC (SESN) United States $0.079B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.075B 0.00
Proteostasis Therapeutics (PTI) United States $0.072B 0.00
Catalyst Biosciences (CBIO) United States $0.071B 0.00
AnPac Bio-Medical Science (ANPC) China $0.070B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.069B 0.00
Synlogic (SYBX) United States $0.069B 0.00
Happiness Biotech Group (HAPP) China $0.068B 0.00
Stealth BioTherapeutics (MITO) United States $0.066B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.061B 0.00
Vaccinex (VCNX) United States $0.060B 0.00
Idera Pharmaceuticals (IDRA) United States $0.058B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.057B 0.00
Soligenix (SNGX) United States $0.055B 0.00
CollPlant Holdings (CLGN) Israel $0.054B 0.00
Signal Genetics (MGEN) United States $0.054B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.053B 0.00
Vascular Biogenics (VBLT) Israel $0.052B 0.00
Ecology Coatings (ABVC) United States $0.051B 0.00
Pulmatrix (PULM) United States $0.049B 0.00
Curis (CRIS) United States $0.047B 0.00
Edesa Biotech (EDSA) Canada $0.045B 0.00
Apricus Biosciences (SEEL) United States $0.044B 0.00
AmpliPhi Biosciences (ARMP) United States $0.043B 0.00
Prima BioMed (IMMP) Australia $0.042B 0.00
ATyr Pharma (LIFE) United States $0.040B 0.00
Bionano Genomics (BNGO) United States $0.040B 0.00
Advaxis (ADXS) United States $0.035B 0.00
Acorda Therapeutics (ACOR) United States $0.034B 0.00
Cesca Therapeutics (THMO) United States $0.034B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.033B 0.00
Chanticleer Holdings (SONN) United States $0.032B 0.00
OvaScience (MLND) United States $0.032B 0.00
Spherix (AIKI) United States $0.030B 0.00
Aptevo Therapeutics (APVO) United States $0.030B 0.00
Titan Pharmaceuticals (TTNP) United States $0.029B 0.00
Novogen (KZIA) Australia $0.027B 0.00
Alimera Sciences (ALIM) United States $0.027B 0.00
Evogene (EVGN) Israel $0.027B 0.00
BioPharmX (TMBR) United States $0.026B 0.00
Cleveland BioLabs (CBLI) United States $0.026B 0.00
IMMURON (IMRN) Australia $0.026B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.024B 0.00
FORTE BIOSCIENC (FBRX) United States $0.024B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.022B 0.00
Prana Biotechnology (ATHE) Australia $0.022B 0.00
Entera Bio (ENTX) Israel $0.021B 0.00
Genetic Technologies (GENE) Australia $0.020B 0.00
MYOS RENS Technology (MYOS) United States $0.016B 0.00
BioCardia (BCDA) United States $0.016B 0.00
Neuralstem (SNCA) United States $0.013B 0.00
VIVUS (VVUS) United States $0.012B 0.00
AEterna Zentaris (AEZS) United States $0.011B 0.00
TRACON Pharmaceuticals (TCON) United States $0.010B 0.00
Benitec Biopharma (BNTC) Australia $0.008B 0.00
Innate Pharma S.A (IPHA) France $0.000B 0.00